Bruna Antunes Teixeira

Bruna Antunes Teixeira

Auto-generated profile, based on publicly available information

Bruna Antunes Teixeira

Universidade Federal de Santa Maria, Brasil

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
Verified
Journal Article
Open access
PDF file
LSL.G. Santos
L.G. Santos
JHJ.A. Hasan
J.A. Hasan
BTB.A. Teixeira
B.A. Teixeira
AVAltevir Rossato Viana
Altevir Rossato Viana
AKA. Krause
A. Krause
This report describes a dog with anemia and ITP, associated with phenobarbital, treated with prednisolone with a good response after association with three intravenous transplantations of 2.5x106 allogenic Mesenchymal Stem-Cells. After the first transplantation, the number of platelets had an improvement, but started to decrease after three weeks. However, the dose of corticosteroid could be reduced. After the second and third administrations, new increases were observed. The platelet count varied from 102,000 to 365,000 until the end of follow-up and without increase of prednisolone doses. Although phenobarbital therapy has been associated with thrombocytopenia, it was not possible to change the anti-convulsant therapy. The response to corticosteroid-based therapy was partial. Cell therapy was followed by an improvement in platelet count with no observed side effects and therefore could be considered safe. Effects on platelet count were transitory, but until the end of follow-up, no severe thrombocytopenia was observed. Based on the observation that platelet numbers dropped a few weeks after cell therapy, more applications would be beneficial in order to maintain higher platelet counts.

1 January 2026 in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
Verified
Journal Article
Open access
BTB.A. Teixeira
B.A. Teixeira
CMCarollina Mariga
Carollina Mariga
Suzana Rossato FeltrinSuzana Rossato Feltrin
Suzana Rossato Feltrin
KMK.M. Marques
K.M. Marques
AAAlfredo Quites Antoniazzi
Alfredo Quites Antoniazzi
SFSaulo Tadeu Lemos Pinto Filho
Saulo Tadeu Lemos Pinto Filho
Multicentric lymphoma is the most common hematopoietic neoplasia in dogs, with chemotherapy being the standard treatment. Medicinal cannabis, especially cannabidiol (CBD), has been studied as a complementary therapy to mitigate symptoms and adverse effects of chemotherapy. This study reports two cases of dogs with multicentric lymphoma treated for two months with chemotherapy and cannabis oil. Both received the cyclosphosphamide, doxorubicin, vincristine, and prednisolone (CHOP) protocol combined with full-spectrum 3% cannabis oil for 60 days. The results suggest that medicinal cannabis may have helped reduce side effects, particularly in modulating myelotoxicity, with variations in neutropenia between cases. Additionally, one of the dogs showed reduced thiobarbituric acid reactive substances (TBARS) levels, suggesting a possible antioxidant effect of CBD. These findings indicate that cannabis oil may be a promising adjunct therapeutic option in the treatment of multicentric lymphoma in dogs, aiding in the management of chemotherapy-related adverse effects. However, individual responses vary, highlighting the need for further studies to clarify the mechanisms involved and establish more effective therapeutic protocols. This research reinforces the potential of medicinal cannabis as an ally in veterinary oncology, expanding perspectives for new therapeutic approaches.

15 July 2024 in Acta Scientiae Veterinariae
Verified
Journal Article
Open access
PDF file
CMCarollina Mariga
Carollina Mariga
BTBruna Antunes Teixeira
Bruna Antunes Teixeira
SFSaulo Tadeu Lemos Pinto Filho
Saulo Tadeu Lemos Pinto Filho
Background: The presence of the endocannabinoid system (ECS) in the skin is unique, and the complexity among receptors, cannabinoids, enzymes, and cells involved results in various processes encompassing this microenvironment. The ECS involves CB1 and CB2 receptors in keratinocytes, nerve fibers, dermal cells, melanocytes, sweat glands, and hair follicles. This intricate interaction represents a therapeutic potential still scarce in veterinary medicine. Therefore, this study aims to report the topical use of Cannabis oil to aid in the healing of a surgical wound that presented suture dehiscence in the postoperative period. Case: A 6-year-old female Great Dane canine experienced suture dehiscence after undergoing surgical excision. The owner reported local discomfort with pain and itching, leading to difficulty in wound care. A full-spectrum Cannabis oil rich in cannabidiol (CBD) was prescribed, with instructions for local application on the wound edges and directly on the lesion twice daily until resolution. The owner reported clinical improvement after the first application, applying only once daily for the remainder of the treatment. The animal exhibited accelerated healing, and the owner was satisfied with the ease of wound care, concluding the treatment in seven days. Discussion: The involvement of the ECS with TRPV, TRPA, TRPM, GPR, GlyR, and adenosine (A2A) receptors located in various skin cell types results in functions such as maintaining the cutaneous barrier, cellular growth and differentiation, and immune and inflammatory processes. It has also been associated with the imbalance of the ECS contributing significantly to skin injuries, including the link between wounds and pain. CBD can increase adenosine signaling, resulting in anti-inflammatory effects, along with the ability to interact with other nuclear and vanilloid receptors with analgesic and anti-itch effects, thus acting in the initial phase of healing, transitioning to a less intense phase, and accelerating the overall process. The ECS is not only present extracellularly but also involves intracellular interactions through nuclear receptors and signaling pathways, allowing for epigenetic modulation to promote analgesia and healing. Some studies have shown that the presence of CBD leads to negative regulation of genes involved in healing and inflammation. CB2 receptor agonists in the wound microenvironment improve local unregulated inflammation through pro-inflammatory cytokines and transforming pro-inflammatory macrophages into anti-inflammatory ones. Additionally, in chronic wounds, the anti-inflammatory properties inhibit the proliferation of hyperproliferative keratinocytes. The topical application of phytocannabinoids and the reduction of the animal's local discomfort can be explained through the presence of CB1 and CB2 cannabinoid receptors in skin nerve fibers, decreasing their excitation and, consequently, itching. Skin homeostasis is intrinsically linked to the ECS through the regulation of various aspects of cell proliferation, differentiation, and inflammatory signalling. Despite limited publications, evidence suggests that the topical application of cannabinoids is effective in cutaneous disorders, including chronic or acute wounds. It can be concluded that the treatment with full-spectrum Cannabis oil rich in CBD applied topically has proven to be a good therapeutic option in cases of surgical wound dehiscence in dogs and has high therapeutic potential in chronic and/or complicated diseases.

1 January 2026 in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
Verified
Journal Article
Open access
CMCarollina Mariga
Carollina Mariga
LSL.G. Santos
L.G. Santos
BFB.P. Freitas
B.P. Freitas
BTB.A. Teixeira
B.A. Teixeira
EVE.L. Villa
E.L. Villa
SFSaulo Tadeu Lemos Pinto Filho
Saulo Tadeu Lemos Pinto Filho
Healing cutaneous lesions and the management of pruritus are common challenges in veterinary practice, significantly impacting animal welfare. The application of Cannabis-based products has emerged as an innovative alternative in the treatment of these conditions. This case report describes the positive outcome of the topical use of a product containing phytocannabinoids for the management of pruritus and wound healing in a dog. The endocannabinoid system (ECS), present in the skin, plays a crucial role in modulating inflammation and tissue regeneration, acting well beyond the CB1 and CB2 receptors. These receptors are responsible for regulating physiological processes such as pruritus control and the promotion of healing. In cases of intense pruritus, self-trauma caused by the animal presents a major challenge to therapeutic management, exacerbating lesions and delaying recovery. Self-trauma, common in dermatitis and other pruritic conditions, can lead to secondary complications such as infections and compromise the patient’s well-being. The use of cannabidiol, due to its anti-inflammatory and antipruritic properties, has shown efficacy in controlling self-trauma and accelerating healing, offering a promising alternative to conventional treatment, in addition to contributing to the improvement of the animal’s physical and psychological well-being.

29 September 2026 in Acta Scientiae Veterinariae
Verified
Journal Article
Open access
PDF file
BTBruna Antunes Teixeira
Bruna Antunes Teixeira
CMCarollina Mariga
Carollina Mariga
Suzana Rossato FeltrinSuzana Rossato Feltrin
Suzana Rossato Feltrin
KMKatielle Martins Marques
Katielle Martins Marques
CACinthia Melazzo de Andrade
Cinthia Melazzo de Andrade
SFSaulo Tadeu Lemos Pinto Filho
Saulo Tadeu Lemos Pinto Filho
Background: Lymphoma is one of the most prevalent malignant neoplasms in dogs and may occur in various anatomical locations. The multicentric form is the most common, accounting for approximately 75% of canine lymphoma cases. Given the high incidence and clinical significance of this disease, this study aimed to evaluate clinical staging, oxidative profile, and interleukin expression in dogs diagnosed with multicentric lymphoma at the time of diagnosis. Materials, Methods & Results: Dogs with cytological diagnoses of multicentric lymphoma, without prior treatment or concurrent diseases, were included. Eleven dogs were evaluated through standardized oncological examination, including lymph node measurement, imaging exams for clinical staging, hematological analysis, oxidative stress biomarkers, and gene expression of IL-6, IL-10, and VEGF in polymorphonuclear (PMN) and peripheral blood mononuclear cells (PBMC). Results were obtained at diagnosis, before treatment initiation. Statistical analysis included absolute and relative frequencies for qualitative variables and means and standard deviations for quantitative variables. Most animals were classified in advanced stages, with 72.7% in stage IV and 27.3% in stage V, and all presented generalized lymphadenomegaly. Substage b was observed in 54.5% of patients, with clinical signs including hyporexia, fever, respiratory distress, and hemorrhagic manifestations. Hematological alterations were detected in 90.9% of cases, including anemia and thrombocytopenia, with thrombocytopenia significantly associated with clinical signs (P < 0.05), suggesting prognostic relevance. Leukogram findings were variable and nonspecific, including leukocytosis, leukopenia, neutrophilia, and lymphocyte alterations. IL-6 expression was low in both PBMC and PMN, whereas IL-10 was more frequently expressed in PMN. VEGF showed high expression, particularly in PMN (100%) and PBMC (77.8%), suggesting an important role in tumor angiogenesis and progression. Oxidative stress analysis demonstrated alterations in TBARS, reactive oxygen species (ROS), catalase, glutathione S-transferase (GST), and myeloperoxidase, indicating disruption of redox homeostasis at diagnosis. It was concluded that multicentric lymphoma is a systemic disease that disrupts body homeostasis and directly impacts prognosis. Advanced staging (IV-V), hematological alterations, including thrombocytopenia, and high VEGF expression at diagnosis were associated with a poorer prognosis. Discussion: The findings reinforce that multicentric lymphoma is a systemic disease frequently diagnosed at advanced stages, contributing to severe clinical presentation and unfavorable prognosis. The high frequency of stages IV and V reflects both aggressive biological behavior and the difficulty of early detection in clinical practice. Hematological alterations, particularly thrombocytopenia, were associated with clinical manifestations and may serve as accessible prognostic indicators. The low IL-6 expression may be related to the predominance of B-cell lymphomas, while elevated VEGF expression supports its role in angiogenesis, tumor maintenance, and disease progression, potentially being associated with worse clinical outcomes. Oxidative stress markers highlight an imbalance between pro-oxidant and antioxidant mechanisms, contributing to tumor development and systemic impairment. Despite limitations such as small sample size and absence of immunophenotyping, the integration of clinical, hematological, oxidative, and molecular findings provides a broader understanding of the pathophysiology of canine multicentric lymphoma and may contribute to improving prognostic evaluation and therapeutic approaches. Keywords: neoplasia, cancer, biomarkers, oxidative status.